Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting

• Main Authors: Mayara Costa de Camargo (Author), Bruna Cipriano Almeida Barros (Author), Izabela Fulone (Author), Marcus Tolentino Silva (Author), Miriam Sanches do Nascimento Silveira (Author), Iara Alves de Camargo (Author), Silvio Barberato-Filho (Author), Fernando de Sá Del Fiol (Author), Luciane Cruz Lopes (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Biological agents used for the treatment of psoriatic arthritis (PsA) and rheumatoid arthritis (RA) are associated with serious adverse effects (SAEs). Although several biologics have demonstrated good efficacy and tolerability in short-term trials, treatment guidelines recommend them as...